{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:16:38Z","timestamp":1790813798424,"version":"4.1.0"},"reference-count":13,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2020,5,1]]},"DOI":"10.1001\/jamadermatol.2020.0352","type":"journal-article","created":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T15:01:40Z","timestamp":1584543700000},"page":"570","source":"Crossref","is-referenced-by-count":47,"title":["Association of Afamelanotide With Improved Outcomes in Patients With Erythropoietic Protoporphyria in Clinical Practice"],"prefix":"10.1001","volume":"156","author":[{"given":"Debby","family":"Wensink","sequence":"first","affiliation":[{"name":"Porphyria Center Rotterdam, Center for Lysosomal and Metabolic Disease, Department of Internal Medicine, Erasmus MC, University Medical Center, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margreet A. E. M.","family":"Wagenmakers","sequence":"additional","affiliation":[{"name":"Porphyria Center Rotterdam, Center for Lysosomal and Metabolic Disease, Department of Internal Medicine, Erasmus MC, University Medical Center, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmin","family":"Barman-Aks\u00f6zen","sequence":"additional","affiliation":[{"name":"Institute of Laboratory Medicine, Municipal Hospital Triemli, Z\u00fcrich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith C. H.","family":"Friesema","sequence":"additional","affiliation":[{"name":"Porphyria Center Rotterdam, Center for Lysosomal and Metabolic Disease, Department of Internal Medicine, Erasmus MC, University Medical Center, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. H. Paul","family":"Wilson","sequence":"additional","affiliation":[{"name":"Porphyria Center Rotterdam, Center for Lysosomal and Metabolic Disease, Department of Internal Medicine, Erasmus MC, University Medical Center, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost","family":"van Rosmalen","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Erasmus MC, University Medical Center, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janneke G.","family":"Langendonk","sequence":"additional","affiliation":[{"name":"Porphyria Center Rotterdam, Center for Lysosomal and Metabolic Disease, Department of Internal Medicine, Erasmus MC, University Medical Center, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"8","key":"dbr200002r1","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/exd.2014.23.issue-8","article-title":"Evidence and conjecture about mechanisms of cutaneous disease in photodermatology.","volume":"23","author":"Porter","year":"2014","journal-title":"Exp Dermatol"},{"key":"dbr200002r2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1750-1172-4-19","article-title":"Erythropoietic protoporphyria.","volume":"4","author":"Lecha","year":"2009","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"dbr200002r3","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/cphy.c120006","article-title":"Porphyrin and heme metabolism and the porphyrias.","volume":"3","author":"Bonkovsky","year":"2013","journal-title":"Compr Physiol"},{"issue":"3","key":"dbr200002r4","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1111\/bjd.2006.155.issue-3","article-title":"Erythropoietic protoporphyria in the UK: clinical features and effect on quality of life.","volume":"155","author":"Holme","year":"2006","journal-title":"Br J Dermatol"},{"issue":"6","key":"dbr200002r5","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1111\/bjd.1994.131.issue-6","article-title":"Erythropoietic protoporphyria.","volume":"131","author":"Todd","year":"1994","journal-title":"Br J Dermatol"},{"issue":"1","key":"dbr200002r6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/ijd.2013.53.issue-1","article-title":"Cutaneous porphyrias part II: treatment strategies.","volume":"53","author":"Tintle","year":"2014","journal-title":"Int J Dermatol"},{"issue":"1","key":"dbr200002r7","first-page":"84","article-title":"A systematic review of treatment options for dermal photosensitivity in erythropoietic protoporphyria.","volume":"55","author":"Minder","year":"2009","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"issue":"suppl 3","key":"dbr200002r8","first-page":"iii52","article-title":"a-MSH related peptides: a new class of anti-inflammatory and immunomodulating drugs.","volume":"66","author":"Luger","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"dbr200002r9","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1056\/NEJMoa1411481","article-title":"Afamelanotide for erythropoietic protoporphyria.","volume":"373","author":"Langendonk","year":"2015","journal-title":"N Engl J Med"},{"issue":"6","key":"dbr200002r10","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1111\/bjd.2015.172.issue-6","article-title":"Long-term observational study of afamelanotide in 115 patients with erythropoietic protoporphyria.","volume":"172","author":"Biolcati","year":"2015","journal-title":"Br J Dermatol"},{"issue":"4","key":"dbr200002r11","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1001\/archderm.1965.01600160007002","article-title":"Erythropoietic protoporphyria. Report of a family and a clinical review.","volume":"92","author":"Lynch","year":"1965","journal-title":"Arch Dermatol"},{"issue":"1","key":"dbr200002r12","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1001\/archderm.1974.01630070026004","article-title":"Erythropoietic protoporphyria: a clinical study based on 29 cases in 14 families.","volume":"110","author":"Schmidt","year":"1974","journal-title":"Arch Dermatol"},{"issue":"1","key":"dbr200002r13","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1586\/17512433.2014.956089","article-title":"Afamelanotide (CUV1647) in dermal phototoxicity of erythropoietic protoporphyria.","volume":"8","author":"Minder","year":"2015","journal-title":"Expert Rev Clin Pharmacol"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2762869\/jamadermatology_wensink_2020_br_200002.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T03:19:39Z","timestamp":1666149579000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2762869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,1]]},"references-count":13,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2020.0352","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5,1]]}}}